AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011
May 5, 2011
30583_dirs_2011-05-05_c9c131fc-0600-4050-9475-bb0d899db562.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-05-03
Reporting Person: ASELAGE STEVE (EVP, Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-29 | Common Stock | A | 1597 | $11.6365 | Acquired | 31478 | Direct |
| 2011-05-03 | Common Stock | M | 10311 | $17.33 | Acquired | 41789 | Direct |
| 2011-05-03 | Common Stock | S | 10311 | $27.1453 | Disposed | 31478 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-03 | Stock Option (right to buy) | $17.33 | M | 10311 | Disposed | 2017-06-06 | Common Stock (10311) | Direct |
Footnotes
F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2010 to April 29, 2011.
F2: The price in Column 4 is a weighted average price. The prices actually received range from $27.00 to $27.35. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: Original option vests 6/48ths on December 7, 2007 and 1/48th on the 7th of every month thereafter.